Sharp Shalini

Filings by Sharp Shalini span 3 companies, the busiest being BeOne Medicines Ltd., Mirati Therapeutics, Inc. and Neurocrine Biosciences Inc. We count 11 filings; the first trade dates from 14 January 2022 and the latest from 11 June 2026.

Purchases make up the whole of the open-market record (2 purchases). The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants and 2 option exercises. In 2026 alone, the filings show 2 purchases and no sales.

On 16 June 2026 came the latest disclosure, an open-market purchase in BeOne Medicines Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.